rs148346599

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2

The NM_182961.4(SYNE1):​c.2995G>A​(p.Glu999Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00257 in 1,614,220 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 25 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

4
6
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.47
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.007960141).
BP6
Variant 6-152453618-C-T is Benign according to our data. Variant chr6-152453618-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 281136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152453618-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 425 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.2995G>A p.Glu999Lys missense_variant 25/146 ENST00000367255.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.2995G>A p.Glu999Lys missense_variant 25/1461 NM_182961.4 P1Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.00279
AC:
424
AN:
152214
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00372
Gnomad FIN
AF:
0.0200
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00200
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00365
AC:
917
AN:
251422
Hom.:
8
AF XY:
0.00388
AC XY:
527
AN XY:
135884
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00333
Gnomad FIN exome
AF:
0.0202
Gnomad NFE exome
AF:
0.00219
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00255
AC:
3730
AN:
1461888
Hom.:
25
Cov.:
31
AF XY:
0.00265
AC XY:
1924
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00949
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00383
Gnomad4 FIN exome
AF:
0.0198
Gnomad4 NFE exome
AF:
0.00173
Gnomad4 OTH exome
AF:
0.00250
GnomAD4 genome
AF:
0.00279
AC:
425
AN:
152332
Hom.:
6
Cov.:
32
AF XY:
0.00352
AC XY:
262
AN XY:
74486
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.0118
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00393
Gnomad4 FIN
AF:
0.0200
Gnomad4 NFE
AF:
0.00200
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.0246
Hom.:
754
Bravo
AF:
0.00121
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00233
AC:
20
ExAC
AF:
0.00336
AC:
408
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00147
EpiControl
AF:
0.00172

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024SYNE1: BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxSep 10, 2018- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 05, 2018- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 13, 2015- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.38
T;.;T;.;.;.;T
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D
MetaRNN
Benign
0.0080
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M;.;.;M;.;M;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.9
D;.;D;D;D;D;D
REVEL
Benign
0.17
Sift
Uncertain
0.0030
D;.;D;D;T;D;T
Sift4G
Uncertain
0.0080
D;D;D;D;D;D;D
Polyphen
0.99
D;.;.;D;D;.;D
Vest4
0.38
MVP
0.64
MPC
0.31
ClinPred
0.026
T
GERP RS
6.0
Varity_R
0.40
gMVP
0.31

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148346599; hg19: chr6-152774753; COSMIC: COSV54941953; API